Thumbay Lab for AI in Healthcare launched
This cutting-edge facility is designed to support and enhance existing AI programs at GMU, providing a dynamic learning and research hub for students, faculty, and healthcare professionals. It offers access to advanced tools and technologies that enable learners to explore real-world AI applications across diagnostics, healthcare operations, medical decision-making, and patient care. The lab is a key infrastructure addition under the Thumbay College of Management and AI in Healthcare and complements a suite of academic programs, including:
Master in Artificial Intelligence and Health Informatics (MAIHI)
Certificate Course in Artificial Intelligence in Healthcare
Certificate Course in Generative AI (GenAI) in Healthcare
These programs are already open for admission and are designed to equip professionals and technologists with the skills to lead in AI-integrated healthcare environments. More details can be found on the official website: www.gmu.ac.ae.
Speaking at the occasion, Dr. Thumbay Moideen stated: 'This lab reflects our commitment to integrating artificial intelligence into every aspect of medical education and healthcare delivery. It will serve as a catalyst for innovation, supporting students and researchers as they develop solutions that shape the future of healthcare.' Prof. Manda Venkatramana, Acting Chancellor of Gulf Medical University and Vice Chancellor – Academics, added: 'This lab will significantly enrich the academic experience of our students by giving them hands-on exposure to emerging technologies. It also opens new avenues for collaborative research, innovation, and real-world problem solving in healthcare.' As part of its strategic ecosystem, the Thumbay College of Management and AI in Healthcare is proud to be collaborating with over 15 leading industry partners, including health-tech innovators, AI solution providers, and academic collaborators who contribute to real-time learning and industry-relevant project development.
Established in 1998 in Ajman, UAE, Gulf Medical University is one of the most dynamic and largest private medical universities in the region. It offers a wide range of accredited programs in medicine, dentistry, pharmacy, health sciences, nursing, healthcare management, and AI in healthcare. With a unique academic health system, strong global partnerships, and a deep commitment to research and innovation, GMU continues to shape the future of healthcare by producing globally competent professionals equipped for tomorrow's challenges.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
2 hours ago
- Zawya
Saudi German Health UAE is setting a new standard in patient experience
Dubai, UAE — Saudi German Health UAE, one of the region's most prominent healthcare networks, has completed a critical milestone in its ongoing transformation to embed 'hospitality-caliber' service into the heart of healthcare operations. In partnership with CXM, a strategic experience transformation partner, the hospital is reimagining what it means to 'care like family'- not as a slogan, but as a lived, system-wide reality. From Vision to Execution: Embedding 'Hospitality-Caliber' Care into the Hospitals Operating Model What began months ago as a vision to reimagine how patients are treated not just medically, but emotionally and operationally has evolved into a structured, hospital-wide program. Today, with Phase 2 finalized, Saudi German Health UAE continues this journey with renewed momentum and system-wide alignment. 'Patient Experience is built when people don't just follow steps, they believe in the purpose behind them. At Saudi German Health UAE, we've been aligning care, culture, and operations around one shared truth: experience is not an initiative, it's how we lead, how we work, and how we serve.' – Ahmed Eissa, Group CEO, Saudi German Health UAE Every touchpoint, team interaction, and daily routine is being re-examined through the lens of experience: how care is felt, not just how it is delivered. In collaboration with CXM, more than 850 team members stepped into a journey of reflection, co-creation, and cultural alignment. From leadership presence to frontline dialogue, the hospital activated new ways of working rooted in empathy, clarity, and shared purpose. Experience by Design: Realigning Hospital Teams Around Purpose and Patient Outcomes Now, as the transformation moves forward, Saudi German Health UAE is preparing to enter its next chapter: co-designing the behavioral and experiential elements that will bring the philosophy of Caring Like Family to life in even deeper, more human-centered ways. This will include reimagining onboarding, empowering peer-to-peer recognition, enhancing patient journey design, and creating signature moments that leave lasting emotional impact. 'What Saudi German Health UAE has chosen isn't easy. But it's real. And it shows what's possible when patient experience is treated not as a layer but as the operating system.' – Raluca Berchiu, Founder & CEO, CXM How Saudi German Health UAE is Setting a Benchmark in Patient Experience Saudi German Health UAE is among the first healthcare institutions in the UAE to treat 'hospitality-caliber' service as essential infrastructure equal in importance to clinical protocols and operational workflows. This is about building emotional connection with patients, a level of personalization and attentiveness they expect from other industries but rarely experience in healthcare. CXM continues to support this evolution translating vision into operational reality, ensuring 'hospitality-caliber' experience is not just felt, but sustained. About Saudi German Health UAE Saudi German Health UAE is one of the region's most prominent healthcare networks, dedicated to delivering world-class medical care with a human touch. Grounded in the philosophy of Caring Like Family, it continues to raise the bar for what excellence in healthcare truly feels like. About CXM CXM is a strategic transformation partner helping hospitals and healthcare systems lead in a patient-centred era. With a focus on growth, operational excellence, and experience innovation, CXM supports healthcare leaders in embedding lasting change across performance, culture, and care delivery. Through its Hospitality-Driven Patient Experience Model, CXM translates bold experience visions into operational reality guiding transformation from strategy to execution
Khaleej Times
3 hours ago
- Khaleej Times
How this UAE-based VR tech helps cancer patients regain mental strength
For many cancer patients, the hardest part begins when treatment ends. The pain may linger, but it's the psychological toll — the fear, the anxiety, the loss of direction, that often proves more enduring. A UAE-based startup, X-Technology, is now offering a form of support that doesn't come in a pill or a counselling session, but through a virtual reality headset. "We don't work with cancer, we work with the psyche," says Nargiz Noimann-Zander, the founder of X-Technology. "We don't treat the diagnosis. We help with what the diagnosis does to a person's emotional state." Through immersive VR-based exercises, the system invites users to externalise and confront their fears. Wearing a headset, the user is transported in one of their games into a galactic scene where two spheres float in space. The instruction is simple but surreal: place the same fear inside both spheres using only your mind. Then, focus until the spheres collide in an explosion of virtual stardust. "You need to try to hold the fear inside each sphere and make them come closer," David, CTO of X-Technology and Nargiz's son explains. "When they come close, you see a flow. That means you're on the right track. It's all mind-driven." A new frontier in emotional support Nargiz has spent over 25 years at the intersection of psychology, neuroscience, and technology. A certified expert in psychosomatics, coaching, NLP and clinical psychology, she began experimenting with tech-based therapy as far back as 1997. Her motivation was deeply personal. "One of my sons had serious heart issues when he was a child, and that's when I started looking into using computer games as a gentle way to support healing," she shared in the interview. That moment marked the beginning of what would become decades of innovation in psychotechnology. "Our story began long before the X-Technology brand was born," she says. "Back in 1997, we founded the Health Centre — a space where doctors, psychologists, and neuroscientists came together to find gentle, science-backed ways to help people heal." Between 1999 and 2003, her team focused on biofeedback-based methods to better understand psychophysiological states. From 2003 to 2009, they started experimenting with computer games not as entertainment, but as tools for emotional and cognitive support. "On modest Pentium systems, we built the very first prototypes of game-based interventions," she recalls. The concept matured from 2009 to 2017 as they combined gaming with biofeedback and real patient experience. In 2017, the transition to VR opened new doors, offering deeply immersive, personalised environments for therapy and recovery. By 2019, AI, virtual assistants, and digital twins became part of the equation. Today, the result is a platform that is being used in clinics, educational settings, and corporate wellness programmes around the world. Importantly, the devices are not connected to the internet. "We're very worried about the data," David says. "We don't connect to Wi-Fi or the cloud. Everything is stored offline inside the headset. I don't want anybody to know what's happening in my brain." Tackling the emotional aftermath of illness Professor Sam Abuomar, Director of the Artificial Intelligence Master's Programme at Lewis University and a visiting professor at the American University of Sharjah, is currently leading a study on the impact of X-Technology's platform on patients undergoing cancer recovery and those with chronic illnesses. "The VR experience has a positive impact because it emulates certain emotional states or past experiences," he explains. "Especially for high-risk patients — those with conditions like cancer or those undergoing chemotherapy — this type of immersive support can improve their emotional and psychological well-being." The mental skills it targets include memory, emotion, and trauma processing. In one future iteration, the system might be tailored to mimic a user's past experiences — working in a factory, being with family — to evoke comforting familiarity. "In our literature review, we came across about 15 studies conducted between 2020 and 2025," says Abuomar. "All of them showed promising results. For example, a 2023 Cleveland Clinic study on 52 cancer patients using interactive therapeutic VR reported significant reduction in depression. Another European study in 2025 on surgical patients found a significant reduction in intraoperative pain." Although their current study is in early stages, Abuomar and his students have begun testing with a sample of 10 patients. Their goal is to compare results between traditional therapy and VR-based support. "If this proves successful, it could be a big step for this kind of tech-based mental health intervention," he adds. Real users, real effects Maria Efimova, 34, a clinical psychologist based in Moscow, has been using the headset for more than two years. She was one of the first to experiment with early versions of the system and now incorporates it into her own practice. "The benefits have been tremendous," she says. "I've seen a significant reduction in anxiety, fears of public speaking, and constant worrying. When I face health-related stress or even physical pain, this is the first thing I turn to. It's like having a coach on call.' Efimova uses two main programmes: one for dissolving fears and another for working with body-related projections. "My mother uses them too. I often recommend it to my clients. Even after one session, I feel less tension and more calmness." A deeply personal mission For Nargiz, the journey is about more than just innovation — it's about restoring humanity to healing. In addition to leading international research centres and authoring nine books, she is also the mother of eight children and grandmother of three. "When future technologies meet a deep understanding of human consciousness, we access a whole new level of self-awareness and possibility," she says. Her mission is clear: to merge science and technology with empathy, helping people across the world not just survive illness, but rebuild emotionally and psychologically. "It's not about fighting the disease. It's about helping people face what it does to their mind and soul - and giving them the tools to rise again."
Zawya
5 hours ago
- Zawya
Dubai hosts the 6th edition of the Middle East, Africa and Russia Hematology Summit 'MASH'
Saudi Arabia - The Hematology Medical Conference, sponsored by AbbVie, the global research and development company in the field of biopharmaceuticals, kicked off for the sixth consecutive year at the Intercontinental Festival City, Dubai, UAE. This summit represents a major regional collaboration for medical affairs in the field of hematology, with a robust history of collaboration in five previous successful versions. The summit featured a group of elite national and international experts and more than 25 speakers from across the Middle East, Africa, and Russia, as well as international speakers, including a hematologist from Canada and an AI expert from healthcare practitioners from the United States. This year's Hematology Summit, in its sixth version, focused more on clinical experience, devoting a full day of its program to workshops for hematologists and clinical pharmacists to share their experiences in managing challenging cases. Additionally, specialized workshops on AI role in healthcare and precision medicine, particularly in hematological diseases, were led by an international expert in artificial intelligence. Dr. Ayman Al-Hijazi, Consultant Hematologist, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia, commended the holding of the 6th Hematology Summit and the attendance of that elite group of consultants and hematology experts. The conference showcased the latest diagnostic methods and various advanced treatments in hematology oncology, including AML, CLL, lymphoma, and others. Dr. Ayman also praised the valuable lectures included in the conference, which showcased advancements in the treatment of recurrent or refractory multiple myeloma, as well as revolutionary advances in cancer research and the transformative use of artificial intelligence in diagnosis and personalized treatment strategies. Dr. Abdulwahab Al-Babtain, Consultant Hematologist and Cellular Therapist at King Faisal Specialist Hospital and Research Center in Riyadh, welcomed everyone who participated in the success of this summit. He added that the summit addressed new developments in the treatment of benign and malignant blood diseases and tumors. The conference also featured extensive scientific and medical content, including scientific papers presented and workshops, including workshops on lymphoma and leukemia, management of complications resulting from blood cancers, treatment sequencing for chronic lymphocytic leukemia, and the importance of detecting genetic mutations in acute myeloid leukemia. Dr. Abdulwahab explained that there has been significant development in medications for treating blood diseases, which will significantly contribute to controlling the disease and alleviating patients' suffering. This is based on the latest clinical studies and how to choose the appropriate treatment for each individual case, in accordance with the latest scientific recommendations in this field. Dr. Ashraf Daoud, General Manager of AbbVie Saudi Arabia, emphasized that such scientific summits align with AbbVie's mission and its focus on medical education, training, scientific research, and providing distinguished medical care, in line with the Kingdom's Vision 2030. This was evident in this version of the conference, which showcased the role of AI in accurate disease diagnosis, discussed new treatments for unmet clinical needs, and highlighted the importance of early detection and optimal management of the disease, with the goal of improving patients' lives.
